A peer support community, independent and not for sale. Since February 2024.

GLP CircleA peer support community

eating

Alcohol: what changes

Many members find drinking changes on these medicines — less desire, worse effects, or both. What is actually known, and the safety points that are not negotiable.

9 min read1.2k wordsUpdated 30 June 2026Reviewed by Benedikt

What members report

This is one of the most consistent unofficial findings in our whole community, and one of the least well evidenced.

A large number of members describe wanting alcohol less. Not deciding to drink less — simply not thinking about it, or opening a bottle of wine and losing interest after a glass, or noticing in month four that the two beers on a Friday have quietly stopped happening. Members who had thought of their drinking as a fixed feature of their week are often the most surprised.

A second, overlapping group report that alcohol lands differently. Faster, or heavier, or with a worse next day. Several describe two drinks producing what three or four used to. And a third group report no change at all, which is worth saying because the internet has decided this effect is universal and it is not.

Benedikt, who holds maintenance and coming-off and has relapse-aware behaviour support training, reviews this guide. His one framing note: none of what follows is a reason to be pleased with yourself or ashamed of yourself. Drinking changing or not changing is a physiological observation, not a character report.

What is actually known

Less than the confident posts suggest, and more than nothing.

The large trials in this class — STEP 1 (Wilding, NEJM, 2021), SURMOUNT-1 (Jastreboff, NEJM, 2022), SELECT (Lincoff, NEJM, 2023) — did not study alcohol intake as an outcome. So the headline weight and cardiovascular results tell us nothing at all about drinking.

What does exist is a body of preclinical work showing GLP-1 receptor agonists reducing alcohol intake in animals, a set of observational analyses in people, and a small number of early clinical studies specifically examining alcohol use. The direction is reasonably consistent and the quality is early. It is an active research area rather than a settled one, and treatment for alcohol use disorder is not an approved use of these medicines anywhere.

The mechanism people propose is that GLP-1 signalling reaches reward pathways as well as appetite pathways, which would explain why the change members describe is about wanting rather than about tolerating. That is plausible and it is not proven in humans.

Sunil’s reading group rule applies with unusual force here: an animal study plus an enthusiastic headline is not a finding about you. If somebody tells you these drugs cure alcohol dependence, they have gone several steps past the evidence.

The safety points, which are not negotiable

Everything above is interesting. This section is the part that matters.

  • If you take insulin or a sulfonylurea, alcohol raises your risk of low blood sugar, and it can do so hours later, including overnight. These medicines already change that picture. This is a specific conversation to have with your prescriber, and the symptoms of hypoglycaemia are on the red-flag list. Do not treat this as general advice you have heard before; drinking on insulin while eating much less than you used to is a genuine risk.
  • Alcohol is a diuretic. On top of reduced fluid intake and reduced thirst signalling, it dehydrates you faster than it used to. Hydration and electrolytes is the companion page and the next-day headache is usually this.
  • Heavy alcohol use is a leading cause of pancreatitis. Given the label warning on this drug class, that overlap is worth taking seriously — see the pancreatitis guide.
  • Alcohol worsens reflux, and reflux on a slow stomach is already a common problem. That guide has the evening-shaped advice.
  • Drinking on very little food is different from drinking on a full stomach. Members report this as the single biggest practical change: the same amount of alcohol on four mouthfuls of dinner is not the same event.
  • Liver disease, medicines that interact, and pregnancy all change the calculation entirely and belong with your own clinician.

The practical version

From members who kept drinking and members who stopped, both.

  • Eat something first, even a little. The most repeated piece of practical advice in the circle.
  • Water alongside. Dull, effective.
  • Assume less than you think. Members who tested their old capacity report regretting it, sometimes memorably.
  • Watch the fizzy ones. Beer, prosecco and anything carbonated combine badly with a slow stomach; several members switched to something still and found the problem largely disappeared.
  • Notice the sugary mixers if you have diabetes and are monitoring glucose.
  • Do not drive on your old assumptions. If alcohol is hitting differently, your judgement about being fit to drive is based on a body you no longer have.
  • Expect the next day to be worse. Widely reported, poorly understood, and the reason a number of members stopped drinking without ever deciding to.

When the change is unwelcome, and when it is a relief

Both happen and both come up in circle.

Some members grieve it, quietly. Wine with dinner, a pint after work, a round with friends — these are social structures and pleasures, not just substances, and losing interest in them can leave a gap. Members describe feeling faintly disloyal to their own social life. Benedikt’s response, from the maintenance circle, is that this is the same conversation as losing interest in a favourite meal: a real loss, worth naming, and not one you have to defend or hurry through.

For others it is one of the most welcome things that has happened. Members with a long and complicated relationship with drinking have described the quiet as a reprieve they had stopped expecting. Several have said, carefully, that it did for their drinking what it did for their eating.

Two honest cautions with that. First, nobody should regard a medication as treatment for a drinking problem, because it has not been established as one and because relying on it means having no plan if it stops working or you stop taking it. Second — and Benedikt is firm here — if drinking is a difficulty in your life, that deserves proper support in its own right rather than a side effect. Our alcohol circle is peer support and it is honest about that limit, and our support-resources page lists the kinds of services worth finding.

What happens if you stop the medicine

Worth thinking about before it is relevant.

The trial evidence about stopping concerns appetite and weight: STEP 4 (Rubino, JAMA, 2021) and SURMOUNT-4 (Aronne, JAMA, 2024) both showed that when treatment is withdrawn, the physiology it was acting on returns. Nobody has studied whether a reduced desire to drink also returns, but the honest expectation is that it may, because it is the same signalling.

Members who came off — some by choice, some because of cost, some because of side effects — have reported exactly that in coming-off: drinking creeping back to where it had been, sometimes before they noticed. Benedikt’s view is that this is worth having a plan for rather than discovering, particularly for anyone who found the change a relief. Coming off, what to expect covers the wider picture.

And the framing he insists on in that circle applies here too: a return of something is not a moral failure. It is what happens when a treatment stops. What matters is noticing, and having somebody to say it to.

Sources

  1. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002. (STEP 1 — alcohol intake was not an outcome)
  2. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205–216. (SURMOUNT-1)
  3. Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221–2232. (SELECT)
  4. Rubino D, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance. JAMA. 2021;325(14):1414–1425. (STEP 4)
  5. Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction. JAMA. 2024;331(1):38–48. (SURMOUNT-4)

We name the trial, the journal and the year, because vague confidence is how people get hurt.

Read next

eating

Dining out without dread

Restaurants when your stomach holds a starter and everybody at the table has noticed. Practical arrangements, and how members handle the commentary.

8 min · reviewed by Ada · updated 19 Feb 2026

eating

Hydration and electrolytes

Thirst goes quiet along with appetite, and most early headaches and cramps in this community trace back to fluid. What is sensible, and where the supplement talk goes wrong.

9 min · reviewed by Mira · updated 27 Mar 2026

symptoms

Pancreatitis: the symptoms to know

Uncommon, serious, and the reason this community has a low threshold for getting abdominal pain seen. The presentation, the evidence, and what to do.

8 min · reviewed by Mira · updated 19 Jun 2026

symptoms

Reflux and burping

Why a slower stomach pushes acid the wrong way, what members changed about evenings and sleep, and the reflux symptoms that are worth a proper conversation.

8 min · reviewed by Tomás · updated 27 Feb 2026

clinical

Coming off: what to expect

Stopping is an ordinary shape, not a failure — what the withdrawal trials found, what the weeks afterwards tend to feel like, and what is worth arranging first.

10 min · reviewed by Benedikt · updated 9 Jul 2026

symptoms

When a symptom needs a clinician

The short list this community keeps: the symptoms that mean seek urgent care today rather than asking a forum. Written to be read once now, before anything is wrong.

9 min · reviewed by Tomás · updated 8 Jul 2026